Clinical Oncology
Volume 20, Issue 3 , Pages 212-220 , April 2008

Concomitant Boost Radiotherapy Compared with Conventional Radiotherapy in Squamous Cell Carcinoma of the Head and Neck — a Phase III Trial from a Single Institution in India

Received 18 July 2007 ,Revised 22 January 2008 ,Accepted 30 January 2008.

References 

  1. Fletcher GH. The textbook of radiotherapy. 2nd edn.. Philadelphia: Lea and Febiger; 1973;140
  2. Knee R, Fields RS, Peters LJ, et al. Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 1985;4:1–7
  3. Parsons JR, Bova FJ, Million RR, et al. A re-evaluation of split-course technique for squamous cell carcinoma of head and neck. Int J Radiat Oncol Biol Phys. 1980;6:1645–1652
  4. Sasaki T, Sato Y, Sakka M, et al. Cell population kinetics in human solid tumours: a statistical analysis in various histological types. Jpn J Cancer Res. 1980;71:520–529
  5. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7–16
  6. Cox JD, Stetz J, Pajak TF, et al. Toxicity criteria of Radiation Therapy Oncology Group (RTOG) and European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–1346
  7. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence world wide. IARC Cancer Base no. 5, version 2.0. Lyon: IARC Press; 2004;
  8. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin. 1996;(65):5–27
  9. Kramer S, Gelber RD, Snow JB, et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer; final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg. 1987;10:19–30
  10. Parson JT, Mendenhall WM, Cassisi NJ, et al. Hyperfractionation in head and neck cancer. Int J Radiat Oncol Biol Phys. 1988;14:649–658
  11. Brizel DM, Albers ME, Fishers SR, et al. Hyperfractionation irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338:1798–1804
  12. Pignon JP, Bourhis J, Domenge C, et al. On behalf of the MACH-NC Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta analyses of updated individual data. Lancet. 2000;355:949–955
  13. Garden AS, Asper JA, Morrison WH, et al. Concurrent chemo-radiation is the treatment of choice for all patients of stage III and stage IV head and neck carcinoma?. Cancer. 2004;100:1171–1178
  14. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91(24):2081–2086
  15. Denis F, Garaud P, Bardet E, et al. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC and NCI-CTC scoring systems. Int J Radiat Oncol Biol Phys. 2003;55(1):93–98
  16. Fu KK, Michelle BS, Ang KK, et al. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09. Int J Radiat Oncol Biol Phys. 1995;32:589–597
  17. Gwozdz JT, Morrison WH, Garden AS, et al. Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa. Int J Radiat Oncol Biol Phys. 1997;39:127–135
  18. Horiot JC, Bontemps P, Bogaert WVD, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves locoregional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol. 1997;44:111–121
  19. Jackson SM, Weir LM, Hay JH, et al. A randomized trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 1997;43:39–46
  20. Overgaard J, Hansen HS, Specht L, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomized controlled trial. Lancet. 2003;362:933–940
  21. Poulsen MG, Denhamb JW, Peters LJ, et al. A randomized trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group study. Radiother Oncol. 2001;60:113–122
  22. Allal AS, Taussky D, Mach N, et al. Can concomitant boost accelerated radiotherapy be adopted as routine treatment for head and neck cancers? A 10-year single institution experience. Int J Radiat Oncol Biol Phys. 2004;58:1431–1436
  23. Ang KK, Peters LJ, Webers RS, et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys. 1990;19:1339–1345
  24. Mackenzie R, Balogh J, Choo R, et al. Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1999;45:589–595
  25. Thames HD, Peters LJ, Withers HR, Fletcher GH. Accelerated fractionation vs. hyperfractionation rationale for several treatments per day. Int J Radiat Oncol Biol Phys. 1983;9:127–138
  26. Jayarajan K, Kar DC, Sahu R, et al. BARC develops cobalt-60 teletherapy machine for cancer treatment. Available at: http://www.barc.ernet.in/webpages/letter/2005(accessed 1 July 2007)
  27. Bourhis J, Overgaard J, Audry H, et al. On behalf of the Meta-analysis of Radiotherapy in Carcinomas of Head and Neck (MARCH) collaborative group hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. 2006;368:843–854
  28. Mac AC, Morisson WH, Garden AS, et al. Base of tongue carcinoma: treatment results using concomitant boost radiotherapy. Int J Radiat Oncol Biol Phys. 1995;33:289–296
  29. Cooper JS, Ang KK. Concomitant chemotherapy and radiation therapy certainly improves local control. Int J Radiat Oncol Biol Phys. 2005;61:7–9
  30. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091–2098
  31. Brizel DM. Radiotherapy and concurrent chemotherapy for treatment of locally advanced head and neck squamous cell carcinoma. Semin Radiat Oncol. 1998;8:237–246
  32. Zackrisson B, Mercke C, Strander H, Wennerberg J, Cavallin Stahl E. A systematic overview of radiation therapy effects in head and neck cancer. Acta Oncol. 2003;42:443–461
  33. Kumar S, Pandey M, Lal P, et al. Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial. Radiother Oncol. 2005;75:186–192
  34. Mohanty BK, Umapathy H, Bahadur S, Thakar A, Pathy S. Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer. AIIMS study. Radiother Oncol. 2004;71:275–280
  35. Kanders JH, Van-Daal WA, Hoogenraad WJ, et al. Accelerated fractionation radiotherapy for laryngeal cancer, acute and late toxicity. Int J Radiat Oncol Biol Phys. 1992;24:497–503
  36. Eishburg A, Ten Haken RK, Kim HM, et al. Dose volume and functional relationship in parotid salivary gland following conformal and intensity modulated irradiation in head and neck cancer. Int J Radiat Oncol Biol Phys. 1998;41:559–568

PII: S0936-6555(08)00057-5

doi: 10.1016/j.clon.2008.01.011

Clinical Oncology
Volume 20, Issue 3 , Pages 212-220 , April 2008

Article Tools

* Image Usage & Resolution